Stay updated on Danirixin Safety & Efficacy in Adult Influenza Clinical Trial

Sign up to get notified when there's something new on the Danirixin Safety & Efficacy in Adult Influenza Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Danirixin Safety & Efficacy in Adult Influenza Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page displays the completed danirixin influenza study record, including its design, eligibility criteria, locations, outcomes, and publication. It also provides information on sharing individual participant data and links to the supporting study documents.
    Difference
    86%
    Check dated 2026-11-08T05:17:16.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The site footer's revision label changes from v3.7.2 to v3.8.0 on a page displaying a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T02:46:22.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    A sitewide notice announces NIH website changes and says federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T02:46:43.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T02:35:27.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T03:54:23.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    A 403 Forbidden page is now served for the study record, and the content infrastructure around the page (e.g., IPD sharing links, consent forms, SAP, and protocol details) appears to be removed or inaccessible, effectively blocking access to the study details and related materials.
    Difference
    21%
    Check dated 2026-09-20T01:44:40.000Z thumbnail image

Stay in the know with updates to Danirixin Safety & Efficacy in Adult Influenza Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Danirixin Safety & Efficacy in Adult Influenza Clinical Trial page.